243 related articles for article (PubMed ID: 29214494)
1. Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.
Kim KW; Jeong S; Ahn KB; Yang JS; Yun CH; Han SH
J Microbiol; 2017 Dec; 55(12):973-978. PubMed ID: 29214494
[TBL] [Abstract][Full Text] [Related]
2. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
Yang JS; An SJ; Jang MS; Song M; Han SH
PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
[TBL] [Abstract][Full Text] [Related]
3. A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses.
Yang JS; Kim HJ; Yun CH; Kang SS; Im J; Kim HS; Han SH
J Microbiol Methods; 2007 Nov; 71(2):141-6. PubMed ID: 17888533
[TBL] [Abstract][Full Text] [Related]
4. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
Yang JS; Choi S; Kim DD; Kang SS; Yun CH; Lee K; Han SH
J Microbiol Methods; 2009 Dec; 79(3):289-94. PubMed ID: 19796659
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
8. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
Svennerholm AM
Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
[TBL] [Abstract][Full Text] [Related]
10. Vibrio cholerae O139 capsular polysaccharide confers complement resistance in the absence or presence of antibody yet presents a productive target for cell lysis: implications for detection of bactericidal antibodies.
Attridge SR; Holmgren J
Microb Pathog; 2009 Dec; 47(6):314-20. PubMed ID: 19818394
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.
Gupta RK; Szu SC; Finkelstein RA; Robbins JB
Infect Immun; 1992 Aug; 60(8):3201-8. PubMed ID: 1639490
[TBL] [Abstract][Full Text] [Related]
12. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
Losonsky GA; Lim Y; Motamedi P; Comstock LE; Johnson JA; Morris JG; Tacket CO; Kaper JB; Levine MM
Clin Diagn Lab Immunol; 1997 May; 4(3):264-9. PubMed ID: 9144361
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination.
Rijpkema SG; Jansen WH; Gielen H; Guinée PA
Microb Pathog; 1987 Nov; 3(5):365-75. PubMed ID: 2462153
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
[TBL] [Abstract][Full Text] [Related]
15. Correlates of Protection for Cholera.
Iyer AS; Harris JB
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S732-S737. PubMed ID: 34668561
[TBL] [Abstract][Full Text] [Related]
16. [Systemic immunity of experimental animals immunized with cholera vaccines].
Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
[TBL] [Abstract][Full Text] [Related]
17. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh.
Qadri F; Svennerholm AM; Shamsuzzaman S; Bhuiyan TR; Harris JB; Ghosh AN; Nair GB; Weintraub A; Faruque SM; Ryan ET; Sack DA; Calderwood SB
Infect Immun; 2005 Oct; 73(10):6577-83. PubMed ID: 16177333
[TBL] [Abstract][Full Text] [Related]
18. Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies.
Grandjean C; Wade TK; Ropartz D; Ernst L; Wade WF
Pathog Dis; 2013 Mar; 67(2):136-58. PubMed ID: 23620159
[TBL] [Abstract][Full Text] [Related]
19. Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.
Lagos R; Avendaño A; Prado V; Horwitz I; Wasserman S; Losonsky G; Cryz S; Kaper JB; Levine MM
Infect Immun; 1995 Feb; 63(2):707-9. PubMed ID: 7822046
[TBL] [Abstract][Full Text] [Related]
20. Vibriocidal assays to determine the antibody titer of patient sera samples.
Son MS; Taylor RK
Curr Protoc Microbiol; 2011 Nov; Chapter 6():Unit6A.3. PubMed ID: 22045586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
